Surgery Partners appoints Lloyd Dean as independent director, enhancing its board with extensive healthcare leadership experience.
Quiver AI Summary
Surgery Partners, Inc. announced the appointment of Lloyd Dean as an independent director on its Board of Directors. Dean, the former CEO of CommonSpirit Health, brings extensive experience from his leadership roles in major health systems, where he focused on enhancing clinical quality and community health. Recognized for his contributions to reducing health disparities and public health advocacy, he has also advised various Presidential Administrations. Dean currently serves on multiple corporate boards and is a Senior Advisor to Bain Capital. Surgery Partners Chairman Blair Hendrix emphasized the value of Dean's insights for the company's growth in high-quality outpatient surgical care. Dean expressed enthusiasm for joining the board amid the company's expansion opportunities.
Potential Positives
- Lloyd Dean's appointment as an independent director brings extensive leadership experience from his tenure at CommonSpirit Health, enhancing the board's expertise.
- Mr. Dean is a nationally recognized healthcare leader, which may strengthen Surgery Partners' credibility and influence in the healthcare industry.
- The announcement indicates Surgery Partners' ongoing growth and commitment to improving outpatient surgical care, signaling confidence in its future prospects.
Potential Negatives
- Mr. Dean's previous role at CommonSpirit Health raises concerns about potential operational challenges or controversies associated with the nonprofit health system, which may reflect on Surgery Partners.
- The need for an independent director signals a potential governance issue or lack of internal expertise, which may negatively impact stakeholder confidence.
- While Mr. Dean is a recognized leader, his extensive commitments to other boards and roles may raise concerns about his availability and dedication to Surgery Partners' strategic objectives.
FAQ
Who is Lloyd Dean?
Lloyd Dean is the former CEO of CommonSpirit Health and a newly appointed independent director of Surgery Partners' Board.
What experience does Lloyd Dean bring to Surgery Partners?
Mr. Dean has extensive experience in healthcare leadership, particularly in quality improvement and public health initiatives.
What is the main focus of Surgery Partners?
Surgery Partners focuses on providing high-quality, cost-effective surgical and ancillary care through a differentiated outpatient delivery model.
How many locations does Surgery Partners operate?
Surgery Partners operates over 200 locations across 30 states, including ambulatory surgery centers and surgical hospitals.
How can I get more information about Surgery Partners?
For more information, visit the Surgery Partners website at www.surgerypartners.com or contact their Investor Relations.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SGRY Insider Trading Activity
$SGRY insiders have traded $SGRY stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $SGRY stock by insiders over the last 6 months:
- DAVID T DOHERTY (Chief Financial Officer) sold 14,574 shares for an estimated $201,704
- JASON ERIC EVANS (Chief Executive Officer) sold 11,462 shares for an estimated $158,060
- JENNIFER BALDOCK (Chief Admin & Dev Officer) sold 10,082 shares for an estimated $138,123
- MARISSA BRITTENHAM (Chief Strategy Officer) sold 8,785 shares for an estimated $120,354
- DANIELLE BURKHALTER (Chief Human Resources Officer) sold 7,736 shares for an estimated $105,209
- WILLIAM TRENTON WEBB (American Group President) has made 0 purchases and 2 sales selling 2,066 shares for an estimated $28,653.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SGRY Revenue
$SGRY had revenues of $821.5M in Q3 2025. This is an increase of 6.63% from the same period in the prior year.
You can track SGRY financials on Quiver Quantitative's SGRY stock page.
$SGRY Hedge Fund Activity
We have seen 83 institutional investors add shares of $SGRY stock to their portfolio, and 145 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 4,113,052 shares (+111.4%) to their portfolio in Q4 2025, for an estimated $63,546,653
- FMR LLC removed 3,911,694 shares (-37.3%) from their portfolio in Q4 2025, for an estimated $60,435,672
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,079,634 shares (-73.7%) from their portfolio in Q4 2025, for an estimated $47,580,345
- DAVIDSON KEMPNER CAPITAL MANAGEMENT LP added 2,371,464 shares (+inf%) to their portfolio in Q4 2025, for an estimated $36,639,118
- PENTWATER CAPITAL MANAGEMENT LP removed 1,681,000 shares (-14.4%) from their portfolio in Q4 2025, for an estimated $25,971,450
- GOLDMAN SACHS GROUP INC added 1,647,714 shares (+528.2%) to their portfolio in Q4 2025, for an estimated $25,457,181
- INVESCO LTD. removed 1,576,138 shares (-89.6%) from their portfolio in Q4 2025, for an estimated $24,351,332
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SGRY Analyst Ratings
Wall Street analysts have issued reports on $SGRY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 11/17/2025
- UBS issued a "Buy" rating on 11/13/2025
To track analyst ratings and price targets for $SGRY, check out Quiver Quantitative's $SGRY forecast page.
$SGRY Price Targets
Multiple analysts have issued price targets for $SGRY recently. We have seen 8 analysts offer price targets for $SGRY in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Ann Hynes from Mizuho set a target price of $17.0 on 03/05/2026
- A.J. Rice from UBS set a target price of $21.0 on 03/05/2026
- Ryan Langston from TD Cowen set a target price of $20.0 on 03/05/2026
- Ben Hendrix from RBC Capital set a target price of $20.0 on 03/04/2026
- Andrew Mok from Barclays set a target price of $14.0 on 03/03/2026
- Benjamin Rossi from JP Morgan set a target price of $20.0 on 11/24/2025
- Bill Sutherland from Benchmark set a target price of $30.0 on 11/11/2025
Full Release
BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors.
Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in the United States, with 142 hospitals, over 1,000 care sites, 25,000 physicians, and 150,000 employees across 21 states. From 2019 to 2022, he led the formation and integration of CommonSpirit, advancing clinical quality, operational performance, and community health initiatives at national scale. Prior to CommonSpirit, Mr. Dean served as President and CEO of Dignity Health, where he strengthened patient experience, expanded partnerships, and elevated the organization’s leadership in delivering compassionate, high‑quality care.
A nationally recognized healthcare leader, Mr. Dean has long championed efforts to reduce health disparities, strengthen the health care workforce, and advance equitable access to care. He has served as an adviser to multiple Presidential Administrations on issues including the Affordable Care Act and COVID‑19 vaccination efforts. Mr. Dean has also held several federal and state appointments focused on public health, economic development, and workforce planning.
Mr. Dean serves on the boards of McDonald’s Corporation—where he chairs the Board Human Resources & Compensation Committee—Guidehouse, Nox Health, and Progyny, and is a Senior Advisor to Bain Capital. He holds a B.S. in sociology and a master’s degree in educational leadership from Western Michigan University, along with multiple honorary doctorates.
“We are honored to welcome Lloyd to the Surgery Partners Board,” said Blair Hendrix, Chairman of Surgery Partners’ Board of Directors. “Lloyd is a nationally respected leader with deep experience advising health systems and shaping public policy. His insights will be invaluable as we continue to expand high‑quality, cost‑effective surgical care across the country.”
“I am excited to join the Board at a time of meaningful growth and opportunity for Surgery Partners,” said Mr. Dean. “The Company is well positioned to continue leading the shift toward high‑value outpatient surgical care, and I look forward to supporting its important mission.”
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com.
Contact
Surgery Partners Investor Relations
(615) 234-8940
